Concepedia

Ammar Wakil

AW

7

Publications

3.7K

Citations

7

H-Index

2008

Active since

Affiliations

Hull Royal Infirmary(Current)

Mossakowski Medical Research Institute, Polish Academy of Sciences

Universidad de La Frontera

Taichung Veterans General Hospital

Eli Lilly (United States)

Ammar Wakil is an author at Hull Royal Infirmary specializing in medicine, diabetes, and metabolic syndrome.

ORCID

Top concepts

Publications per year

2008–2019

7

Publications

7

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Low dose cabergoline for hyperprolactinaemia is not associated with clinically significant valvular heart disease

Ammar Wakil, Alan S. Rigby, Andrew L. Clark et al. · European Journal of Endocrinology · 2008 · 115 citations · Full text

Enhanced Bioavailability of Eicosapentaenoic Acid from Fish Oil After Encapsulation Within Plant Spore Exines as Microcapsules

Ammar Wakil, Grahame Mackenzie, Alberto Diego‐Taboada et al. · Lipids · 2010 · 73 citations · Full text

, , +12

A comparison of methods for the measurement of 8-isoPGF<sub>2<i>α</i></sub>: a marker of oxidative stress

Karen Smith, J. Shepherd, Ammar Wakil et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2011 · 57 citations

Rows per page

1–5 of 7